Seth Rudnick is of G1 Therapeutics, Inc.. Currently has a direct ownership of 4,389 shares of GTHX, which is worth approximately $31,381. The most recent transaction as insider was on Jun 29, 2021, when has been sold 10,000 shares (Common Stock) at a price of $22.35 per share, resulting in proceeds of $223,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.39K
0% 3M change
0% 12M change
Total Value Held $31,381

SETH RUDNICK Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 29 2021
SELL
Open market or private sale
$223,500 $22.35 p/Share
10,000 Reduced 69.5%
4,389 Common Stock
Jun 29 2021
BUY
Exercise of conversion of derivative security
$3,500 $0.35 p/Share
10,000 Added 41.0%
14,389 Common Stock
Jun 17 2021
BUY
Grant, award, or other acquisition
-
4,389 Added 50.0%
4,389 Common Stock
SR

Seth Rudnick

Research Triangle Park, NC

Track Institutional and Insider Activities on GTHX

Follow G1 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GTHX shares.

Notify only if

Insider Trading

Get notified when an G1 Therapeutics, Inc. insider buys or sells GTHX shares.

Notify only if

News

Receive news related to G1 Therapeutics, Inc.

Track Activities on GTHX